| Issue Date | Title | Author(s) |
| 2020-11-01 | Exploring the Economic Benefits of Modafinil for Post-Stroke Fatigue in Australia: A Cost-Effectiveness Evaluation | Bajorek, B; Gao, L; Lillicrap, T; Bivard, A; Garcia-Esperon, C; Parsons, M; Spratt, N; Holliday, E; Levi, C |
| 2020-01 | Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease. | Wadhwa, R; Paudel, KR; Mehta, M; Shukla, SD; Sunkara, K; Prasher, P; Panth, N; Goyal, R; Chellappan, DK; Gupta, G; Hansbro, PM; Aljabali, AAA; Tambuwala, MM; Dua, K |
| 2021-01-01 | Circadian Rhythm Disruption and Alzheimer's Disease: The Dynamics of a Vicious Cycle. | Sharma, A; Sethi, G; Tambuwala, MM; Aljabali, AAA; Chellappan, DK; Dua, K; Goyal, R |
| 2020-11-01 | Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis | Chan, Y; Ng, SW; Mehta, M; Anand, K; Kumar Singh, S; Gupta, G; Chellappan, DK; Dua, K |
| 2021-09 | Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: A Hypothesis | Kaur, J; Gulati, M; Gowthamarajan, K; Vishwas, S; Kumar Chellappan, D; Gupta, G; Dua, K; Pandey, NK; Kumar, B; Singh, SK |
| - | Emerging Targets for Modulation of Immune Response and Inflammation in Stroke | Thapa, K; Shivam, K; Khan, H; Kaur, A; Dua, K; Singh, S; Singh, TG |
| 2021-01-19 | Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. | Jha, NK; Ojha, S; Jha, SK; Dureja, H; Singh, SK; Shukla, SD; Chellappan, DK; Gupta, G; Bhardwaj, S; Kumar, N; Jeyaraman, M; Jain, R; Muthu, S; Kar, R; Kumar, D; Goswami, VK; Ruokolainen, J; Kesari, KK; Singh, SK; Dua, K |
| 2022-03-29 | Role of Brain-Gut-Microbiota Axis in Depression: Emerging Therapeutic Avenues. | Bhatt, S; Kanoujia, J; Mohanalakshmi, S; Patil, CR; Gupta, G; Chellappan, DK; Dua, K |
| 2022-03-27 | Mechanism of mesenchymal stem cells as a multitarget disease-modifying therapy for parkinson's disease. | Unnisa, A; Dua, K; Kamal, MA |
| 2022-01-28 | Biological databases and tools for neurological disorders. | Usman, MB; Ojha, S; Jha, SK; Chellappan, DK; Gupta, G; Singh, SK; Dua, K; Roychoudhury, S; Kumar, N; Khan, FA; Dureja, H; Upadhye, V; Zacconi, F; Prasanna, P; Kesari, KK; Ashraf, GM; Alexiou, A; Jha, NK |
